Cowan; Chad A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cowan; Chad A..The latest application filed is for "dux4 expressing cells and uses thereof".

Company Profile

4.3.19

Cowan; Chad A. - Boston MA
Cowan; Chad A. - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dux4 Expressing Cells And Uses Thereof App 20220267732 - Cowan; Chad A. ; et al.	2022-08-25
Modified T Cells And Methods Of Making And Using The Same App 20220162554 - Meissner; Torsten B. ; et al.	2022-05-26
Modified T Cells And Methods Of Making And Using The Same App 20220162555 - Meissner; Torsten B. ; et al.	2022-05-26
Universal Donor Stem Cells And Related Methods App 20220112459 - Meissner; Torsten B. ; et al.	2022-04-14
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20210285015 - Musunuru; Kiran ; et al.	2021-09-16
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20210274726 - Musunuru; Kiran ; et al.	2021-09-09
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20210277423 - Musunuru; Kiran ; et al.	2021-09-09
Universal Donor Stem Cells And Related Methods App 20210261916 - Meissner; Torsten B. ; et al.	2021-08-26
Methods For Assessing Transendothelial Barrier Integrity App 20210247385 - COWAN; Chad A. ; et al.	2021-08-12
Synergistic Transcription Factors To Induce High Resistance Transendothelial Barrier App 20210222122 - COWAN; Chad A. ; et al.	2021-07-22
Universal Donor Stem Cells And Related Methods App 20210171903 - Meissner; Torsten B. ; et al.	2021-06-10
Universal donor stem cells and related methods Grant 10,968,426 - Meissner , et al. April 6, 2	2021-04-06
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20200048659 - Musunuru; Kiran ; et al.	2020-02-13
Universal Donor Stem Cells And Related Methods App 20190309259 - Meissner; Torsten B. ; et al.	2019-10-10
Therapeutic uses of genome editing with CRISPR/Cas systems Grant 10,208,319 - Musunuru , et al. Feb	2019-02-19
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20180291383 - Musunuru; Kiran ; et al.	2018-10-11
Cells Lacking B2m Surface Expression And Methods For Allogeneic Administration Of Such Cells App 20180141992 - Cowan; Chad A. ; et al.	2018-05-24
Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAs Grant 9,822,370 - Musunuru , et al. November 21, 2	2017-11-21
Modified T Cells And Methods Of Making And Using The Same App 20160348073 - Meissner; Torsten B. ; et al.	2016-12-01
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20150176013 - Musunuru; Kiran ; et al.	2015-06-25
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20150152436 - Musunuru; Kiran ; et al.	2015-06-04
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20150071889 - Musunuru; Kiran ; et al.	2015-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.